Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTL0039732 Monotherapy and Combination Therapy in Advanced Solid Tumours
NCT05944237Phase 2Recruiting
- Sponsor
- Cancer Research UK
- Start
- Aug 2023
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HTL0039732 in solid tumor, sponsored by Cancer Research UK. Started Aug 2023; status: recruiting.
02
Drugs
HTL0039732
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05944237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05944237.